Share Price and Basic Stock Data
Last Updated: October 10, 2025, 1:35 am
PEG Ratio | 0.00 |
---|
Analyst Insight & Comprehensive Analysis
Globe Commercials Ltd, a Trading & Distributors company, currently trades at ₹26.7 with a market capitalization of ₹16.0 Cr and a P/E ratio of 5.26. The company boasts a healthy Return on Equity (ROE) and Return on Capital Employed (ROCE), standing at undisclosed percentages. Notably, Globe Commercials Ltd’s Operating Profit Margin (OPM) is at 3.17%, indicating efficient cost management. With a strong promoter holding of 8.33% and a significant public shareholding of 91.67%, the company enjoys a diverse investor base with 6,358 shareholders. Furthermore, the company’s healthy reserves of ₹282 Cr provide a cushion for future growth, while its low borrowings of ₹3 Cr indicate a conservative capital structure.
Key strengths for Globe Commercials Ltd include its attractive Price-to-Book Value (P/BV) ratio of 1.32x, suggesting the stock may be undervalued compared to its peers in the Trading & Distributors sector. However, the lack of information on Institutional Investor ownership, such as Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs), raises concerns about the company’s ability to attract long-term institutional support. Moving forward, Globe Commercials Ltd could enhance its outlook by improving transparency around its financials, attracting institutional investors to boost market confidence, and diversifying its revenue streams to mitigate sector-specific risks.
In conclusion, Globe Commercials Ltd presents an intriguing investment opportunity with solid financial fundamentals and room for growth. Retail investors should closely monitor the company’s efforts to attract institutional investors and diversify its operations to capitalize on its strengths and navigate potential risks effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Globe Commercials Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Minal Industries Ltd | 76.2 Cr. | 3.97 | 5.59/3.20 | 45.4 | 2.77 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
Mitshi India Ltd | 13.5 Cr. | 15.4 | 19.5/13.0 | 451 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 |
Modella Woollens Ltd | 6.01 Cr. | 66.0 | 74.2/52.5 | 3.63 | 0.00 % | % | % | 10.0 | |
MRC Agrotech Ltd | 76.0 Cr. | 37.1 | 44.4/10.2 | 75.2 | 15.0 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
MRP Agro Ltd | 108 Cr. | 97.5 | 174/84.4 | 14.6 | 29.3 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
Industry Average | 11,158.21 Cr | 168.53 | 103.57 | 113.41 | 0.25% | 15.73% | 9.23% | 7.74 |
Quarterly Result
Metric | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
Sales | 35.26 | 35.98 | 49.86 | 177.81 | 176.55 |
Expenses | 34.40 | 35.08 | 48.44 | 172.40 | 170.95 |
Operating Profit | 0.86 | 0.90 | 1.42 | 5.41 | 5.60 |
OPM % | 2.44% | 2.50% | 2.85% | 3.04% | 3.17% |
Other Income | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.86 | 0.90 | 1.46 | 5.41 | 5.60 |
Tax % | 25.58% | 27.78% | 27.40% | 26.06% | 26.07% |
Net Profit | 0.64 | 0.65 | 1.05 | 4.00 | 4.14 |
EPS in Rs | 1.07 | 1.08 | 1.75 | 6.66 | 6.90 |
Last Updated: January 5, 2025, 8:02 am
Below is a detailed analysis of the quarterly data for Globe Commercials Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Sales, as of Sep 2024, the value is 176.55 Cr.. The value appears to be declining and may need further review. It has decreased from 177.81 Cr. (Jun 2024) to 176.55 Cr., marking a decrease of 1.26 Cr..
- For Expenses, as of Sep 2024, the value is 170.95 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 172.40 Cr. (Jun 2024) to 170.95 Cr., marking a decrease of 1.45 Cr..
- For Operating Profit, as of Sep 2024, the value is 5.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Jun 2024) to 5.60 Cr., marking an increase of 0.19 Cr..
- For OPM %, as of Sep 2024, the value is 3.17%. The value appears strong and on an upward trend. It has increased from 3.04% (Jun 2024) to 3.17%, marking an increase of 0.13%.
- For Other Income, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Interest, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2024, the value is 5.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Jun 2024) to 5.60 Cr., marking an increase of 0.19 Cr..
- For Tax %, as of Sep 2024, the value is 26.07%. The value appears to be increasing, which may not be favorable. It has increased from 26.06% (Jun 2024) to 26.07%, marking an increase of 0.01%.
- For Net Profit, as of Sep 2024, the value is 4.14 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2024) to 4.14 Cr., marking an increase of 0.14 Cr..
- For EPS in Rs, as of Sep 2024, the value is 6.90. The value appears strong and on an upward trend. It has increased from 6.66 (Jun 2024) to 6.90, marking an increase of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2024 |
---|---|
Sales | 162 |
Expenses | 158 |
Operating Profit | 4 |
OPM % | 3% |
Other Income | 0 |
Interest | 0 |
Depreciation | 0 |
Profit before tax | 4 |
Tax % | 27% |
Net Profit | 3 |
EPS in Rs | 5.08 |
Dividend Payout % | 0% |
YoY Net Profit Growth
Year |
---|
YoY Net Profit Growth (%) |
Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 41% |
3 Years: | 79% |
1 Year: | 3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Last Updated: September 5, 2025, 3:36 pm
Balance Sheet
Last Updated: July 25, 2025, 1:12 pm
Month | Mar 2024 | Sep 2024 |
---|---|---|
Equity Capital | 6 | 214 |
Reserves | 6 | 282 |
Borrowings | 1 | 3 |
Other Liabilities | 44 | 79 |
Total Liabilities | 58 | 579 |
Fixed Assets | 0 | 460 |
CWIP | 0 | 0 |
Investments | 3 | 3 |
Other Assets | 55 | 116 |
Total Assets | 58 | 579 |
Below is a detailed analysis of the balance sheet data for Globe Commercials Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is 214.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 214.00 Cr., marking an increase of 208.00 Cr..
- For Reserves, as of Sep 2024, the value is 282.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 282.00 Cr., marking an increase of 276.00 Cr..
- For Borrowings, as of Sep 2024, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is 79.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 44.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 35.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is 579.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.00 Cr. (Mar 2024) to 579.00 Cr., marking an increase of 521.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is 460.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 460.00 Cr., marking an increase of 460.00 Cr..
- For CWIP, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Sep 2024, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
- For Other Assets, as of Sep 2024, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 55.00 Cr. (Mar 2024) to 116.00 Cr., marking an increase of 61.00 Cr..
- For Total Assets, as of Sep 2024, the value is 579.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2024) to 579.00 Cr., marking an increase of 521.00 Cr..
Notably, the Reserves (282.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2024 |
---|---|
Free Cash Flow
Month | Mar 2024 |
---|---|
Free Cash Flow | 3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2024 |
---|---|
Debtor Days | 109 |
Inventory Days | 4 |
Days Payable | 100 |
Cash Conversion Cycle | 14 |
Working Capital Days | 14 |
ROCE % |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 24 |
---|---|
FaceValue | 10.00 |
Basic EPS (Rs.) | 5.09 |
Diluted EPS (Rs.) | 5.09 |
Cash EPS (Rs.) | 5.09 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 20.83 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 20.83 |
Revenue From Operations / Share (Rs.) | 270.52 |
PBDIT / Share (Rs.) | 6.97 |
PBIT / Share (Rs.) | 6.97 |
PBT / Share (Rs.) | 6.97 |
Net Profit / Share (Rs.) | 5.09 |
NP After MI And SOA / Share (Rs.) | 5.09 |
PBDIT Margin (%) | 2.57 |
PBIT Margin (%) | 2.57 |
PBT Margin (%) | 2.57 |
Net Profit Margin (%) | 1.88 |
NP After MI And SOA Margin (%) | 1.88 |
Return on Networth / Equity (%) | 24.43 |
Return on Capital Employeed (%) | 29.94 |
Return On Assets (%) | 5.23 |
Long Term Debt / Equity (X) | 0.11 |
Total Debt / Equity (X) | 0.11 |
Current Ratio (X) | 1.14 |
Quick Ratio (X) | 1.10 |
Enterprise Value (Cr.) | 17.93 |
EV / Net Operating Revenue (X) | 0.11 |
EV / EBITDA (X) | 4.29 |
MarketCap / Net Operating Revenue (X) | 0.10 |
Price / BV (X) | 1.32 |
Price / Net Operating Revenue (X) | 0.10 |
EarningsYield | 0.18 |
After reviewing the key financial ratios for Globe Commercials Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 20.83. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 20.83. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 270.52. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 24, the value is 24.43. This value is within the healthy range. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 24, the value is 29.94. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 24, the value is 5.23. This value is within the healthy range. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.11. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 24, the value is 1.14. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 24, the value is 1.10. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 24, the value is 17.93. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 24, the value is 4.29. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 24, the value is 1.32. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EarningsYield, as of Mar 24, the value is 0.18. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Globe Commercials Ltd:
- Net Profit Margin: 1.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.94% (Industry Average ROCE: 14.9%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.43% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 4.97 (Industry average Stock P/E: 70.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.88%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Trading & Distributors | #51, V Mall, Ground Floor, Asha Nagar, Tahkur Complex, Mumbai Maharashtra 400091 | globemultiventures@gmial.com http://www.globecommercials.com |
Management | |
---|---|
Name | Position Held |
Mr. Mallikarjunan Venkatraman | Ind.& Non Exe.Director |
Mrs. Sivalenka Kameswari | Whole Time Director |
Mr. Satya Murthy Sivalenka | Non Exe.Non Ind.Director |
Mr. Venkat Raman Ayinam | Ind.& Non Exe.Director |
FAQ
What is the intrinsic value of Globe Commercials Ltd?
Globe Commercials Ltd's intrinsic value (as of 10 October 2025) is 503.09 which is 1888.50% higher the current market price of 25.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹15.2 Cr. market cap, FY2025-2026 high/low of 44.0/22.2, reserves of ₹282 Cr, and liabilities of 579 Cr.
What is the Market Cap of Globe Commercials Ltd?
The Market Cap of Globe Commercials Ltd is 15.2 Cr..
What is the current Stock Price of Globe Commercials Ltd as on 10 October 2025?
The current stock price of Globe Commercials Ltd as on 10 October 2025 is 25.3.
What is the High / Low of Globe Commercials Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Globe Commercials Ltd stocks is 44.0/22.2.
What is the Stock P/E of Globe Commercials Ltd?
The Stock P/E of Globe Commercials Ltd is 4.97.
What is the Book Value of Globe Commercials Ltd?
The Book Value of Globe Commercials Ltd is 827.
What is the Dividend Yield of Globe Commercials Ltd?
The Dividend Yield of Globe Commercials Ltd is 0.00 %.
What is the ROCE of Globe Commercials Ltd?
The ROCE of Globe Commercials Ltd is %.
What is the ROE of Globe Commercials Ltd?
The ROE of Globe Commercials Ltd is %.
What is the Face Value of Globe Commercials Ltd?
The Face Value of Globe Commercials Ltd is 10.0.